HSBC has identified its top pharmaceutical stock picks, highlighting companies with strong growth prospects and solid execution strategies across both growth and value categories. The investment ...

Below is Validea's guru fundamental report for HSBC HOLDINGS PLC (ADR) (HSBC). Of the 22 guru strategies we follow, HSBC rates highest using our Twin Momentum Investor model based on the published ...

HSBC analysts just slashed their recommendation on the world's most valuable pharmaceutical company, Eli Lilly, signaling a potential cooling period for the red-hot obesity drug trade that has come to ...

HSBC’s stock (NYSE: HSBC) has performed quite well this year, increasing by approximately 21% since the beginning of January. In comparison, its competitor JP Morgan (NYSE: JPM) is only up about 10% ...

Investors with an interest in Banks - Foreign stocks have likely encountered both HSBC (HSBC) and Banco Santander-Chile (BSAC ...

Investors looking for stocks in the Banks - Foreign sector might want to consider either HSBC (HSBC) or HDFC Bank (HDB). But which of these two stocks offers value investors a better bang for their ...

HSBC Holdings Plc delivered a mixed Q3 2025, with resilient core operations but earnings impacted by litigation and legacy issues. HSBC's net interest income and fee growth were strong, especially in ...

HSBC Holdings is rated Hold, amid a major transition from global lending to pan-Asian wealth integration, with valuation reflecting high expectations. Privatizing Hang Seng Bank unlocks $1.7T in ...

Complete HSBC Holdings PLC ADR stock information by Barron's. View real-time HSBC stock price and news, along with industry-best analysis.

LONDON, UNITED KINGDOM - 2025/04/04: General view of HSBC headquarters in Canary Wharf. (Photo by Vuk Valcic/SOPA Images/LightRocket via Getty Images) HSBC’s stock (NYSE: HSBC) has performed quite ...